Translational Neurotherapeutics Program

Laboratory for Dementia and Parkinsonism

The Laboratory for Dementia and Parkinsonism investigates cellular, biochemical and pathological mechanisms that underlie neurodegenerative diseases with dementia and Parkinsonism, including Alzheimer’s disease (AD) and other dementias, and Parkinson’s disease (PD) and related movement disorders. We also investigate the neuro-pathological and biochemical pathways involved in the spectrum of motor neuron disease (MND) with fronto-temporal dementia (FTD).

In partnership with the Translational Neurotherapeutics Program, the Laboratory for Dementia and Parkinsonism evaluates potential therapeutic drugs for neurodegenerative diseases in pre-clinical models and clinical trials.

Article on Nilotinib by Dr. Charbel Moussa